You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 1, January 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neuromuscular diseases
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Adult-Onset Nemaline Myopathy and Monoclonal Gammopathy

Christian E. Keller, MD; Arthur P. Hays, MD; Lewis P. Rowland, MD; Behzad Moghadaszadeh, PhD; Alan H. Beggs, PhD; Govind Bhagat, MD

Arch Neurol. 2006;63:132-134.

A 45-year-old man with severe proximal muscle weakness had findings diagnostic of adult-onset nemaline myopathy. He also had a monoclonal gammopathy. This is the fifth report of adult-onset nemaline myopathy in a patient with monoclonal gammopathy, suggesting that the occurrence of these entities may be more than a chance association. Myocyte-bound immunoglobulin or light chains were not detected and immunotherapy was not effective in this patient. Other causes of adult-onset nemaline myopathy were ruled out, including the most common mutations of sarcomeric thin filament genes.


Author Affiliations: Department of Pathology (Dr Keller), Division of Neuropathology (Dr Hays), Division of Hematopathology (Dr Bhagat), College of Physicians and Surgeons, Columbia University, New York, NY; Department of Neurology, Neurological Institute of New York, Columbia University Medical Center (Dr Rowland); Genomics Program and Division of Genetics, Children's Hospital Boston, Harvard Medical School, Boston, Mass (Drs Moghadaszadeh and Beggs).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A "nema" of hope in the treatment of late-onset nemaline myopathy
Dalakas and Smith
Neurology 2008;71:472-473.
FULL TEXT  

SPORADIC LATE-ONSET NEMALINE MYOPATHY EFFECTIVELY TREATED BY MELPHALAN AND STEM CELL TRANSPLANT
Voermans et al.
Neurology 2008;71:532-534.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.